Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CHIEF EXECUTIVE OFFICER

SEE REMARKS

CHIEF FINANCIAL OFFICER

See Remarks

Chief Executive Officer

Chief Financial Officer

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeut...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-30	Premium	sold	Premium	Premium	Premium	-
2024-04-29	Premium	sold	Premium	Premium	Premium	-
2024-04-01	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-04-01	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-04-01	Premium	sold	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-04-01	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-01-25	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-01-25	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-01-25	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-01-08	Premium	gifted	Premium	Premium	Premium	-
2024-01-04	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-04	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-04	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-01-04	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-12-14	Premium	sold	Premium	Premium	Premium	See Remarks
2023-12-13	Premium	sold	Premium	Premium	Premium	See Remarks
2023-12-13	Premium	sold	Premium	Premium	Premium	See Remarks
2023-12-13	Premium	acquired	Premium	Premium	Premium	See Remarks
2023-12-12	Premium	sold	Premium	Premium	Premium	See Remarks
2023-12-11	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-12-11	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-12-11	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2023-11-30	Premium	gifted	Premium	Premium	Premium	-
2023-11-30	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2023-11-30	Premium	sold	Premium	Premium	Premium	See Remarks

SLNO - Soleno Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for SLNO